Walleye Trading’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-37,900
Closed -$6.96M 6755
2021
Q2
$6.96M Buy
37,900
+19,400
+105% +$3.33M 0.18% 624
2021
Q1
$2.83M Sell
18,500
-50,200
-73% -$7.77M 0.1% 1065
2020
Q4
$10.7M Sell
68,700
-14,900
-18% -$1.91M 0.32% 365
2020
Q3
$9.57M Sell
83,600
-37,100
-31% -$4M 0.79% 306
2020
Q2
$13.5M Sell
120,700
-15,800
-12% -$1.68M 0.83% 192
2020
Q1
$12.3M Sell
136,500
-59,600
-30% -$5.85M 0.77% 137
2019
Q4
$21.2M Buy
196,100
+102,800
+110% +$11M 0.89% 115
2019
Q3
$9.14M Buy
93,300
+73,300
+367% +$8.26M 0.66% 227
2019
Q2
$2.62M Sell
20,000
-39,800
-67% -$5.13M 0.21% 849
2019
Q1
$8.08M Sell
59,800
-5,300
-8% -$659K 0.6% 310
2018
Q4
$6.34M Buy
65,100
+54,600
+520% +$6.45M 0.25% 369
2018
Q3
$1.46M Sell
10,500
-33,600
-76% -$4.21M 0.04% 1672
2018
Q2
$5.47M Sell
44,100
-24,200
-35% -$2.83M 0.16% 552
2018
Q1
$7.61M Buy
68,300
+19,300
+39% +$2.31M 0.22% 349
2017
Q4
$5.86K Buy
49,000
+17,200
+54% +$2.09M 0.16% 581
2017
Q3
$4.46K Buy
31,800
+4,900
+18% +$666K 0.1% 730
2017
Q2
$3.27K Buy
26,900
+3,600
+15% +$419K 0.11% 846
2017
Q1
$2.82K Buy
23,300
+22,000
+1,692% +$2.84M 0.13% 839
2016
Q4
$159K Sell
1,300
-7,200
-85% -$881K 0.01% 2946
2016
Q3
$1.04M Buy
8,500
+5,000
+143% +$644K 0.06% 1508
2016
Q2
$408K Sell
3,500
-10,600
-75% -$1.5M 0.03% 2390
2016
Q1
$1.96M Sell
14,100
-10,600
-43% -$1.56M 0.21% 868
2015
Q4
$4.71M Buy
24,700
+2,600
+12% +$454K 0.26% 386
2015
Q3
$3.46M Sell
22,100
-155,200
-88% -$28.3M 0.21% 429
2015
Q2
$32M Buy
177,300
+169,400
+2,144% +$29.2M 1.96% 35
2015
Q1
$1.37M Buy
7,900
+7,600
+2,533% +$1.38M 0.1% 827
2014
Q4
$56K Sell
300
-300
-50% -$55.6K ﹤0.01% 3184
2014
Q3
$99K Sell
600
-300
-33% -$49.3K 0.01% 2661
2014
Q2
$141 Buy
+900
New +$142K 0.01% 2230

Other funds holding ALXN